Tennessee lawmakers split as DOJ shift reignites push for medical marijuana rules
Tennessee medical marijuana legislation updates continue to evolve, creating uncertainty for patients seeking evidence-based cannabis treatments. Current state restrictions limit access to comprehensive medical cannabis therapy despite growing clinical…
Avicanna Welcomes Initial U.S. Rescheduling of Medical Cannabis & Provides Scientific Update
The proposed rescheduling of cannabis to Schedule III represents a regulatory milestone that could unlock rigorous clinical research previously restricted under Schedule I classification. This change would enable pharmaceutical-grade development pathways…
Drug Development, Tax Breaks, Future Reimbursement Expected After Medical Marijuana …
Federal policy changes around cannabis drug development tax incentives could reshape medical cannabis access and research funding. Understanding these regulatory shifts helps clinicians prepare for evolving therapeutic landscapes while maintaining focus…
Bumble CBD Gummies: A Practical Guide for Health-Conscious Users Seeking Calm and Balance
CBD gummies offer predictable therapeutic delivery when properly dosed and sourced from quality manufacturers. This CBD gummies dosing guide for therapeutic use provides evidence-based protocols for safe, effective treatment. Understanding onset timing…
Trump’s Orders Elevate The Medical Status Of Psychedelics And Cannabis – Forbes
Federal policy changes around cannabis and psychedelics create significant federal cannabis rescheduling clinical implications for medical practice. Understanding regulatory shifts helps clinicians navigate evolving treatment landscapes while maintaining…
Medicinal cannabis may not help your anxiety or depression, study suggests – MSN
Recent studies questioning medical cannabis anxiety depression effectiveness highlight the need for nuanced clinical understanding. While some patients report benefits, controlled research shows inconsistent results and significant individual…
Cannabis and Mental Health: A Review.
A comprehensive JAMA review reveals the stark gap between widespread cannabis use for mental health conditions and actual clinical evidence. While patients commonly self-medicate with cannabis for psychiatric symptoms, this systematic analysis found…
Randomised Controlled Trial Evidence on Medicinal Cannabis for Treatment of Mental Health and Substance Use Disorders: A Scoping Review.
A comprehensive scoping review of randomized controlled trials reveals limited high-quality medicinal cannabis mental health evidence for treating psychiatric and substance use disorders. The systematic review highlights significant gaps in rigorous…
Leveraging the national cancer institute’s collaborative efforts to understand the benefits and harms of cannabis use among individuals with cancer.
Cannabis use for symptom management among patients with cancer has increased significantly in recent years, with many reporting benefits for pain, anxiety, s...
The role of cannabis-based medicinal products (CBMPs) in managing osteoarthritis symptoms: a scoping review of current evidence and future directions.
This review critically evaluates the therapeutic role of cannabis and its derivatives in managing osteoarthritic pain, with a focus on clinical evidence and ...